- Q1 2024 OncoCyte Corp Earnings Call TranscriptMay 15, 2024$2.95 (+1.72%)Earnings
- Q4 2023 OncoCyte Corp Earnings Call TranscriptApr 12, 2024$2.71 (-8.60%)Earnings
- Q3 2023 OncoCyte Corp Earnings Call TranscriptNov 09, 2023$2.7 (+29.71%)Earnings
- Q2 2023 OncoCyte Corp Earnings Call TranscriptAug 10, 2023$3.51Earnings
- OncoCyte Corp Extraordinary Shareholders Meeting TranscriptJul 24, 2023
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 23, 2023
- Q1 2023 OncoCyte Corp Earnings Call TranscriptMay 11, 2023$5.46 (+2.40%)Earnings
- Q4 2022 OncoCyte Corp Earnings Call TranscriptApr 03, 2023$6.35 (-10.41%)Earnings
- Q3 2022 OncoCyte Corp Earnings Call TranscriptNov 10, 2022$12.01 (+0.05%)Earnings
- OncoCyte Corp at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 11, 2022
- Q2 2022 OncoCyte Corp Earnings Call TranscriptAug 10, 2022$19.02 (+10.57%)Earnings
- OncoCyte Corp DetermalO™ and Tumor Microenvironment in Clinical Practice Key Opinion Leader TranscriptJun 28, 2022
- Q1 2022 OncoCyte Corp Earnings Call TranscriptMay 11, 2022$22.6 (-2.59%)Earnings
- Q4 2021 OncoCyte Corp Earnings Call TranscriptMar 10, 2022$28 (+7.69%)Earnings
- OncoCyte Corp to Discuss Development and Co-Marketing Agreement with Thermo Fisher Scientific Inc Call TranscriptJan 18, 2022
- OncoCyte Corp Investor and Analyst Day TranscriptDec 14, 2021
- Q3 2021 OncoCyte Corp Earnings Call TranscriptNov 09, 2021$71.6 (+0.85%)Earnings
- OncoCyte Corp Key Opinion Leader Presentation Part 2: DetermaIO™ in Triple-Negative Breast Cancer TranscriptSep 28, 2021
- OncoCyte Corp Key Opinion Leader Presentation Part 1: Transplant Rejection Testing TranscriptSep 22, 2021
- Q2 2021 OncoCyte Corp Earnings Call TranscriptAug 10, 2021$100 (-1.96%)Earnings
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 24, 2021
- Q1 2021 OncoCyte Corp Earnings Call TranscriptMay 17, 2021$81.2 (+4.24%)Earnings
- OncoCyte Corp DetermaIO™ Data KOL Webinar TranscriptApr 19, 2021
- Q4 2020 OncoCyte Corp Earnings Call TranscriptMar 16, 2021$102.6 (+3.22%)Earnings
- Q3 2020 OncoCyte Corp Earnings Call TranscriptNov 12, 2020$33.6 (-4.00%)Earnings
- OncoCyte Corp - EGFR And Molecular Risk Stratification In Early-Stage NSCLC TranscriptOct 22, 2020
- OncoCyte Corporation - Special Call TranscriptAug 19, 2020
- Q2 2020 OncoCyte Corp Earnings Call TranscriptJul 29, 2020$27.4 (-4.20%)Earnings
- OncoCyte Corp Announces Completion Of Determadx™ Clinical Validation Study TranscriptJun 29, 2020
- OncoCyte Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 OncoCyte Corp Earnings Call TranscriptMay 12, 2020$54 (-6.57%)Earnings
- Q4 2019 OncoCyte Corp Earnings Call TranscriptMar 25, 2020$39.8 (-1.00%)Earnings
- OncoCyte Corp to Acquire Insight Genetics Inc - Conference Call TranscriptJan 10, 2020
- Q3 2019 OncoCyte Corp Earnings Call TranscriptNov 14, 2019$32.2 (-0.62%)Earnings
- Q2 2019 OncoCyte Corp Earnings Call TranscriptAug 14, 2019$41.8 (-7.93%)Earnings
Q4 2019 OncoCyte Corp Earnings Call Transcript
Greetings, and welcome to the OncoCyte Corporation Fourth Quarter and Fiscal Year 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Bob Yedid, Managing Director at LifeSci Advisors. Thank you. You may begin.
Thank you, Doug, and thank you, everyone, for joining us for today's conference call to discuss Oncocyte's fourth quarter and full year 2019 financial results and recent operating highlights. If you have not seen today's financial results press release, please visit Oncocyte's website at www.oncocyte.com.
Before turning the call over to Ronnie Andrews, Oncocyte's President and Chief Executive Officer, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding the future events. Any statements that are not historical fact including, but not limited to, statements that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)